je.st
news
Tag: phase
Utility Relocation Begins First Phase of Crozet Avenue Project
2013-04-06 18:32:14| Telecom - Topix.net
Dominion Virginia Power has begun a project to remove its overhead power lines and poles from Crozet Avenue through downtown and to supply electricity to buildings there through buried lines.
Tags: project
avenue
phase
begins
Phase Modulated Full-Bridge Controller Features -40°C To 150°C Operating Junction Temperature Range
2013-04-04 06:30:38| rfglobalnet News Articles
Linear Technology Corporation announces the H-grade version of theLTC3722-1, a phase-modulated full bridge DC/DC controller with adaptive or manual zero voltage switching (ZVS).
Tags: range
features
operating
phase
Phase Modulated Full-Bridge Controller Features -40°C To 150°C Operating Junction Temperature Range
2013-04-04 06:30:38| wirelessdesignonline News Articles
Linear Technology Corporation announces the H-grade version of theLTC3722-1, a phase-modulated full bridge DC/DC controller with adaptive or manual zero voltage switching (ZVS).
Tags: range
features
operating
phase
Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
2013-03-28 09:57:29| dairynetwork Home Page
Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.
Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
2013-03-28 09:57:29| dairynetwork News Articles
Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.
Sites : [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] next »